XML 44 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenues $ 338,373 $ 32,001 $ 628,124 $ 512,473
Costs and Expenses        
Cost of revenues 74,271 0 282,825 503,609
Research, development and manufacturing operations 460,775 516,782 1,078,842 2,389,863
Selling, general and administrative 633,566 607,784 1,545,852 2,243,925
Depreciation and amortization 58,154 91,104 185,163 289,324
Total Costs and Expenses 1,226,766 1,215,670 3,092,682 5,426,721
Loss from Operations (888,393) (1,183,669) (2,464,558) (4,914,248)
Other Income/(Expense)        
Other Income, net 6,000 13,144 842,500 13,144
Interest Expense (1,907,895) (1,730,717) (6,740,340) (5,279,259)
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net 1,510,883 3,284,736 6,430,048 2,599,870
Total Other Income/(Expense) (391,012) 1,567,163 532,208 (2,666,245)
Net Loss $ (1,279,405) $ 383,494 $ (1,932,350) $ (7,580,493)
Net Loss Per Share (Basic and Diluted) (in dollars per share) $ (0.001) $ 0.20 $ (0.003) $ (0.45)
Weighted Average Common Shares Outstanding (Basic and Diluted) (in shares) 1,457,404,260 22,739,044 705,196,069 16,827,420